While retailing in the United States has hit a snag, one marked by a dearth of innovation and a scarcity of bold leadership, the state of the art elsewhere in the world is alive and well. While traditional retailers have for now run out of new ideas, the art itself is thriving. Examples abound. In
In an ever-changing retail universe, a world where today’s bright hope is tomorrow’s used-to-be, the National Association of Chain Drug Stores’ Annual Meeting, held each spring, remains the standard by which retail meetings are, or should be, judged.
During the last few months, we’ve seen an intense focus on the cost of medicines, including a Senate hearing featuring seven biopharmaceutical executives.
Over the past few years we’ve all seen the impact of wellness on how customers shop. They are looking for cleaner and more functional ingredients and more organic foods, and even watching what HBC products they are putting on their face and skin.
The industry continues to experience major shifts. And while the relentless pace of change can be daunting, the one thing any of us know for sure is that there’ll be more disruption ahead and standing still is not an option.
Editor’s note: The fifth in a series of seven articles by A.T. Kearney on the trends that are radically transforming the health sector. America faces skyrocketing health care expenses. The Centers for Medicare and Medicaid Services (CMS) projects that national health spending will grow by 5.
The National Association of Chain Drug Stores was at the top of its game during the Regional Chain Conference in Palm Beach, Fla., earlier this month.
In just over two weeks, pharmacy advocates from all 50 states will travel to Washington, D.C. for NACDS RxIMPACT Day on Capitol Hill.
whether shopping in-store or online — as opposed to 29% who shop primarily online, according to results from a recent survey by DXC Technology published in an IDC
Walgreens Boots Alliance has entered the early stages of a profound transition, one that will see the organization pivot from a store-first to a digital-first model.
Editor’s note: This is Part I of an article that ran in the 1/21/19 issue of CDR.
In recent years, a transforming economy and disruptive technology have converged to change the landscape of the consumer packaged goods industry.
Everyone recognizes that the high cost of health care in the U.S. is a chronic problem, the fallout from which is hurting patients, constraining providers and preventing the nation from marshalling adequate resources to address other essential needs.
There has been significant focus and attention paid to the issue of drug prices in the last few years. As Adam Fein, president of Pembroke Consulting Inc. and chief executive officer of Drug Channels Institute, has said, “Drugs are 12% of the costs, but 90% of the conversation.
Editor’s note: The fourth in a series of seven articles by A.T. Kearney on the trends that are radically transforming the health sector. By Todd Huseby and Carol Cruickshank Traditionally, the approach to health in the United States has been reactive or at best responsive.
